Accelerate Diagnostics Inc Net debt/EBITDA
¿Qué es el Net debt/EBITDA de Accelerate Diagnostics Inc?
El Net debt/EBITDA de Accelerate Diagnostics Inc es -2.79
¿Cuál es la definición de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA de compañías en Sector Health Care en NASDAQ en comparadas con Accelerate Diagnostics Inc
¿Qué hace Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Empresas con net debt/ebitda similar a Accelerate Diagnostics Inc
- Synertone Communication tiene Net debt/EBITDA de -2.80
- T. Rowe Price tiene Net debt/EBITDA de -2.80
- VOTI Detection tiene Net debt/EBITDA de -2.80
- Volkswagen AG tiene Net debt/EBITDA de -2.79
- Capital Bancorp Inc tiene Net debt/EBITDA de -2.79
- Tata Consultancy Services tiene Net debt/EBITDA de -2.79
- Accelerate Diagnostics Inc tiene Net debt/EBITDA de -2.79
- SPORTTOTAL AG tiene Net debt/EBITDA de -2.78
- Wildflower Brands tiene Net debt/EBITDA de -2.78
- Equus Mining tiene Net debt/EBITDA de -2.78
- B & S International tiene Net debt/EBITDA de -2.78
- Télévision Française 1 SA tiene Net debt/EBITDA de -2.78
- Palla Pharma tiene Net debt/EBITDA de -2.78